From June 1996 to January 2004, 11 consecutive patients with AA underwent allo-PBT/CD34+ from HLA-identical sibling donors at our institution. The diagnosis of AA was based on the peripheral blood ...
CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors. Prevention of skin cancer and reduction of keratotic skin lesions during ...
Study published in SCIE-indexed international journal Molecular Neurobiology; Three intravenous infusions at four-week ...
Table 1 Clinical and biological characteristics of the 30 patients and their corresponding donors In our experience with a homogeneous population of AML patients, after the same conditioning and GVHD ...
October 24, 2011 — In nonstraightforward bone marrow analysis, the presence of 30% or more CD34+ megakaryocytes is a strong indicator of megaloblastic anemia or a myeloid neoplasm, according to a ...
Expanding on the Cooperative Center of Excellence in Hematology (CCEH) at Fred Hutchinson Cancer Center’s expertise in providing Human CD34+ HSPCs, we have established a high-efficiency and ...
We've had the opportunity to evaluate the CD34+ cell in the past 20 years, and finally we have a tool that represents a potential breakthrough for patients with CMD, said Douglas Losordo, MD, FACC, ...
Unknown primary tumors metastatic to liver. The majority of patients (97%) mobilized CD34+33- cells, which were usually collected in the greatest quantity on the first day of apheresis. Patients who ...
Polycythemia vera is the ultimate phenotypic consequence of the V617F mutation in Janus kinase 2 (encoded by JAK2), but the extent to which this mutation influences the behavior of the involved CD34+ ...
CAMBRIDGE, Mass. & HAIFA, Israel--(BUSINESS WIRE)--Minovia Therapeutics, a clinical-stage company focused on the development of cell-based Mitochondrial Augmentation Technology (MAT) to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results